Vivas-Mejia, Pablo Elias
- University of Puerto Rico Medical Sciences · Biochemistry (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #42,526
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Biochemistry
NIH Funding · FY2023
Linked Award Amount
$150K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#42,526
By linked amount among FY2023 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Vivas-Mejia, Pablo Elias as a PI. Multi-PI records show the full award amount for context.
- 5R16GM145558-02R16Contact PIUnraveling the Role of MMP3 in the Cisplatin Resistance of Ovarian CancerUniversity of Puerto Rico Medical Sciences · Biochemistry (NIH department code)$150Kaward amount
Award organization
Organizations that administered FY2023 awards listing Vivas-Mejia, Pablo Elias as a PI.
FY2023 award administered by University of Puerto Rico Medical Sciences (PR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardUniversity of Puerto Rico Medical Sciences
- 2014$500K Cumulative Funding